Skip to main content
logo
Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.42
-0.33 (-2.81%)
At close: Sep 28, 2026, 4:00 PM EDT
11.49
+0.07 (0.61%)
Pre-market: Sep 29, 2026, 7:47 AM EDT

Intellia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6001,0411,1882,7312,9748,799
Market Cap Growth
-8.60%-12.31%-56.51%-8.18%-66.20%150.41%
Enterprise Value
1,0454693441,8562,2237,727
Last Close Price
11.428.9911.6630.4934.89118.24

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.8915.3920.5275.2757.06266.22
PB Ratio
2.201.551.362.602.418.46
P/TBV Ratio
2.201.551.362.602.418.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.576.945.9551.1742.65233.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.100.140.240.110.110.07
Net Debt / Equity Ratio
-0.76-0.76-0.75-0.85-0.92-0.97
Net Debt / EBITDA Ratio
1.341.191.241.772.513.88
Net Debt / FCF Ratio
1.591.291.842.203.264.26
Asset Turnover
0.070.070.050.030.040.03
Quick Ratio
5.614.425.508.239.455.97
Current Ratio
6.655.085.778.669.626.11
Return on Equity (ROE)
-55.44%-53.48%-54.01%-42.10%-41.67%-34.19%
Return on Assets (ROA)
-30.14%-27.11%-26.80%-22.83%-20.35%-16.99%
Return on Capital Employed (ROCE)
-54.40%-59.70%-49.50%-43.50%-32.90%-22.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-24.99%-39.63%-43.70%-17.62%-15.95%-3.04%
FCF Yield
-21.79%-38.02%-29.87%-14.95%-11.66%-2.70%
Buyback Yield / Dilution
-16.64%-9.64%-11.35%-15.33%-8.57%-26.63%
SEC Filings: 10-K · 10-Q